Elekta AB EBITDA Margin 2013-2025 | EKTAY
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Elekta AB (EKTAY) over the last 10 years. The current EBITDA margin for Elekta AB as of January 31, 2025 is .
| Elekta AB EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-01-31 | $1.68B | $0.28B | 16.34% |
| 2024-10-31 | $1.69B | $0.28B | 16.37% |
| 2024-07-31 | $1.70B | $0.28B | 16.43% |
| 2024-04-30 | $1.71B | $0.30B | 17.54% |
| 2024-01-31 | $1.72B | $0.31B | 18.25% |
| 2023-10-31 | $1.70B | $0.30B | 17.42% |
| 2023-07-31 | $1.65B | $0.27B | 16.10% |
| 2023-04-30 | $1.61B | $0.24B | 14.75% |
| 2023-01-31 | $1.58B | $0.23B | 14.65% |
| 2022-10-31 | $1.56B | $0.24B | 15.04% |
| 2022-07-31 | $1.61B | $0.28B | 17.57% |
| 2022-04-30 | $1.64B | $0.30B | 18.38% |
| 2022-01-31 | $1.61B | $0.30B | 18.81% |
| 2021-10-31 | $1.64B | $0.33B | 20.34% |
| 2021-07-31 | $1.61B | $0.34B | 21.22% |
| 2021-04-30 | $1.58B | $0.36B | 22.60% |
| 2021-01-31 | $1.56B | $0.36B | 23.34% |
| 2020-10-31 | $1.51B | $0.35B | 23.12% |
| 2020-07-31 | $1.49B | $0.32B | 21.22% |
| 2020-04-30 | $1.52B | $0.30B | 20.05% |
| 2020-01-31 | $1.55B | $0.32B | 20.31% |
| 2019-10-31 | $1.54B | $0.30B | 19.28% |
| 2019-07-31 | $1.52B | $0.30B | 19.78% |
| 2019-04-30 | $1.50B | $0.29B | 19.51% |
| 2019-01-31 | $1.49B | $0.29B | 19.62% |
| 2018-10-31 | $1.46B | $0.30B | 20.25% |
| 2018-07-31 | $1.43B | $0.29B | 20.29% |
| 2018-04-30 | $1.37B | $0.27B | 19.55% |
| 2018-01-31 | $1.35B | $0.25B | 18.32% |
| 2017-10-31 | $1.32B | $0.22B | 16.95% |
| 2017-07-31 | $1.25B | $0.20B | 16.28% |
| 2017-04-30 | $1.23B | $0.20B | 16.57% |
| 2017-01-31 | $1.23B | $0.23B | 18.80% |
| 2016-10-31 | $1.24B | $0.19B | 15.60% |
| 2016-07-31 | $1.29B | $0.20B | 15.81% |
| 2016-04-30 | $1.33B | $0.20B | 14.79% |
| 2016-01-31 | $1.35B | $0.14B | 10.57% |
| 2015-10-31 | $1.36B | $0.16B | 11.96% |
| 2015-07-31 | $1.37B | $0.15B | 10.71% |
| 2015-04-30 | $1.37B | $0.11B | 8.08% |
| 2015-01-31 | $1.49B | $0.20B | 13.32% |
| 2014-10-31 | $1.55B | $0.23B | 14.95% |
| 2014-07-31 | $1.58B | $0.25B | 16.09% |
| 2014-04-30 | $1.60B | $0.30B | 18.86% |
| 2014-01-31 | $1.59B | $0.37B | 23.40% |
| 2013-10-31 | $1.60B | $0.38B | 23.67% |
| 2013-07-31 | $1.60B | $0.38B | 23.72% |
| 2013-04-30 | $1.55B | $0.36B | 22.97% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.968B | $1.708B |
| Elekta AB is a human care company engaged in developing and selling clinical solutions for the treatment of cancer and neurological diseases. It develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. The Company's offering is divided into five areas: Neuroscience, Oncology, Software, Brachytherapy and Services. Elekta AB is headquartered in Stockholm, Sweden. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $199.979B | 87.59 |
| Thermo Fisher Scientific (TMO) | United States | $152.379B | 18.43 |
| Edwards Lifesciences (EW) | United States | $45.667B | 29.94 |
| Alcon (ALC) | Switzerland | $42.389B | 28.65 |
| IDEXX Laboratories (IDXX) | United States | $42.210B | 48.51 |
| DexCom (DXCM) | United States | $33.568B | 51.88 |
| IQVIA Holdings (IQV) | United States | $25.587B | 14.33 |
| Mettler-Toledo (MTD) | United States | $24.309B | 28.91 |
| STERIS (STE) | Ireland | $23.816B | 26.23 |
| Waters (WAT) | United States | $21.016B | 29.65 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.484B | 0.00 |
| Hologic (HOLX) | United States | $13.943B | 15.15 |
| Sysmex ADR (SSMXY) | Japan | $10.323B | 29.29 |
| Penumbra (PEN) | United States | $9.888B | 77.61 |
| Masimo (MASI) | United States | $8.836B | 32.59 |
| Globus Medical (GMED) | United States | $8.077B | 19.25 |
| Teleflex (TFX) | United States | $5.424B | 8.95 |
| Glaukos (GKOS) | United States | $5.198B | 0.00 |
| TransMedics (TMDX) | United States | $4.391B | 95.45 |
| Integer Holdings (ITGR) | United States | $4.193B | 21.97 |
| PROCEPT BioRobotics (PRCT) | United States | $3.410B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.425B | 14.44 |
| Nihon Kohden (NHNKY) | Japan | $2.244B | 25.74 |
| Veracyte (VCYT) | United States | $2.137B | 29.99 |
| Alphatec Holdings (ATEC) | United States | $1.795B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.344B | 0.00 |
| Artivion (AORT) | United States | $1.224B | 114.64 |
| Pulse Biosciences (PLSE) | United States | $1.181B | 0.00 |
| OPKO Health (OPK) | United States | $1.067B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.018B | 5.41 |
| Beta Bionics (BBNX) | United States | $0.843B | 0.00 |
| SiBone (SIBN) | United States | $0.788B | 0.00 |
| IRadimed (IRMD) | United States | $0.773B | 39.21 |
| RxSight (RXST) | United States | $0.620B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.577B | 8.97 |
| Delcath Systems (DCTH) | United States | $0.570B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.551B | 12.91 |
| AxoGen (AXGN) | United States | $0.496B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.489B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.445B | 0.00 |
| NeuroPace (NPCE) | United States | $0.432B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.427B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.399B | 10.61 |
| ClearPoint Neuro (CLPT) | United States | $0.364B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.363B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.309B | 0.00 |
| Neuronetics (STIM) | United States | $0.255B | 0.00 |
| 908 Devices (MASS) | United States | $0.247B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.236B | 14.28 |
| Sight Sciences (SGHT) | United States | $0.219B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.207B | 0.00 |
| CVRx (CVRX) | United States | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.173B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.171B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Accuray (ARAY) | United States | $0.164B | 0.00 |
| LENSAR (LNSR) | United States | $0.159B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.157B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.156B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.132B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.111B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.100B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.087B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.080B | 48.90 |
| InspireMD (NSPR) | United States | $0.080B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.065B | 0.00 |
| Hyperfine (HYPR) | United States | $0.055B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| Spectral AI (MDAI) | United States | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.030B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.12 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |